Moreover, the generalisability of previous findings is questionable when comparing different countries, territories, or even urban areas with different environmental characteristics.
With such specious assumptions, the value of the findings is questionable.
However, the validity of these findings was questionable because of potential biases (eg, recall and selection biases) and unadjusted confounding.
We found minor differences in functional outcomes as measured with the 15D, HAAS, and OKS instruments, but the clinical relevance of these findings is questionable.
Considering the emphasis now placed on workplace based assessment as a method of formative performance assessment, there are surprisingly few published articles exploring these areas, and the strength of the findings is questionable.
Considering the emphasis now placed on MSF as a method of formative performance assessment, there are surprisingly few published articles exploring these areas, and the strength of the study findings is questionable.
Although the study by Ferrajoli et al. proposes novel biomarkers for CLL, the clinical utility of these findings is questionable as 30 50% of patients never require therapy at all, and therefore, outside of a clinical trial context, this information is unlikely to result in changes to patient management.
Even that limited finding is questionable.
Noticeably, the interpretation of the main finding is questionable, as the authors state that the lower PI would force the subjects to develop a forward PT (i.e., lower PT) determining a functional anterolateral overcoverage.
